Pharyngitis News and Research

RSS
FDA approves changes to REMS for Nplate and Promacta

FDA approves changes to REMS for Nplate and Promacta

Celgene to discontinue docetaxel and prednisone plus lenalidomide Phase III trial on CRPC

Celgene to discontinue docetaxel and prednisone plus lenalidomide Phase III trial on CRPC

Sore throat among young adults taking antibiotics for acne: Study

Sore throat among young adults taking antibiotics for acne: Study

Swissmedic approves REVLIMID for treatment of myelodysplastic syndromes

Swissmedic approves REVLIMID for treatment of myelodysplastic syndromes

Merck's NEXPLANON 68 mg now available in the U.S.

Merck's NEXPLANON 68 mg now available in the U.S.

Human Genome Sciences to present abstracts regarding BENLYSTA, SLE at ACR/ARHP meeting

Human Genome Sciences to present abstracts regarding BENLYSTA, SLE at ACR/ARHP meeting

Teva reports data from QNASL studies on seasonal and perennial allergic rhinitis

Teva reports data from QNASL studies on seasonal and perennial allergic rhinitis

EC approves Lilly's ALIMTA as continuation maintenance therapy for NSCLC

EC approves Lilly's ALIMTA as continuation maintenance therapy for NSCLC

FDA approves NDA for Edgemont's Fluoxetine 60 mg tablet

FDA approves NDA for Edgemont's Fluoxetine 60 mg tablet

Boehringer Ingelheim receives FDA approval for COMBIVENT RESPIMAT to treat COPD

Boehringer Ingelheim receives FDA approval for COMBIVENT RESPIMAT to treat COPD

Vaxent, PREVENT sign license agreement to develop and commercialize Strep-A vaccine

Vaxent, PREVENT sign license agreement to develop and commercialize Strep-A vaccine

E.U. CHMP issues positive opinion for use of Celgene's REVLIMID/dexamethasone MM drug

E.U. CHMP issues positive opinion for use of Celgene's REVLIMID/dexamethasone MM drug

African Americans more likely than Caucasians to develop and die from lung cancer

African Americans more likely than Caucasians to develop and die from lung cancer

Probiotics appear to protect against upper respiratory tract infections

Probiotics appear to protect against upper respiratory tract infections

FDA accepts Teva's NDA for BDP Nasal HFA to treat allergic rhinitis

FDA accepts Teva's NDA for BDP Nasal HFA to treat allergic rhinitis

Novartis Afinitor Phase III trial on tuberous sclerosis meets primary endpoint

Novartis Afinitor Phase III trial on tuberous sclerosis meets primary endpoint

Celgene announces data from REVLIMID plus rituximab Phase II study on malignant lymphomas

Celgene announces data from REVLIMID plus rituximab Phase II study on malignant lymphomas

Celgene, GELA to conduct REVLIMID/rituximab combination study on newly diagnosed FL

Celgene, GELA to conduct REVLIMID/rituximab combination study on newly diagnosed FL

REVLIMID-R-CHOP Phase I/II data in untreated DLBCL presented at malignant lymphoma conference

REVLIMID-R-CHOP Phase I/II data in untreated DLBCL presented at malignant lymphoma conference

Cinryze data on hereditary angioedema presented at EAACI 2011

Cinryze data on hereditary angioedema presented at EAACI 2011